Related Experiment Video
Updated: May 4, 2026

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Expression of matrix metalloproteinases in patients with bipolar disorder
Fábria Chiarani1, Gabriel Rodrigo Fries1, Laura Stertz1
1Molecular Psychiatry Unit and National Science and Technology Institute for Translational Medicine (INCT-TM), Hospital de Clínicas de Porto Alegre (HCPA), Universidade Federal do Rio Grande do Sul (UFRGS), Porto AlegreRS, Brazil.
Objective:
High cardiovascular mortality rates have been reported in patients with bipolar disorder (BD). Studies indicate that matrix metalloproteinases (MMPs) are implicated in cardiovascular diseases. We evaluated the expression pattern of MMP-2 and MMP-9 in blood from patients with BD during acute mania and after euthymia, in comparison with healthy controls.
Methods:
Twenty patients and 20 controls were recruited and matched for sex and age. MMP messenger RNA (mRNA) levels were measured using real-time quantitative polymerase chain reaction (PCR). Body mass index (BMI) was calculated for all subjects.
Results:
There were no significant differences in MMP-2 and MMP-9 mRNA expression between patients and controls. mRNA levels were not significantly different during mania and euthymia. However, MMP-2 mRNA levels were negatively associated with BMI in BD patients and positively associated with BMI in controls. There was no difference in the pattern of MMP-9 expression between patients and controls.
Conclusions:
Our results suggest a different pattern of association between MMP-2 and BMI in BD patients as compared with controls. Despite some study limitations, we believe that the role of MMPs in BD should be further investigated to elucidate its relationship with cardiovascular risk.
Insights
Matrix metalloproteinases (MMPs) like MMP-2 and MMP-9 show no difference in expression in bipolar disorder (BD) patients versus controls. However, MMP-2 levels correlate differently with body mass index (BMI) in BD patients compared to healthy individuals.
Area of Science:
- Biochemistry
- Psychiatry
- Cardiovascular Medicine
Background:
- Patients with bipolar disorder (BD) exhibit elevated cardiovascular mortality.
- Matrix metalloproteinases (MMPs), specifically MMP-2 and MMP-9, are recognized contributors to cardiovascular diseases.
- Understanding the role of MMPs in BD is crucial for addressing associated cardiovascular risks.
Purpose of the Study:
- To investigate the expression patterns of MMP-2 and MMP-9 in individuals with bipolar disorder (BD).
- To compare MMP expression in BD patients during acute mania and euthymia against healthy controls.
- To explore the relationship between MMP expression and body mass index (BMI) in BD patients.
Main Methods:
- Recruitment of 20 BD patients and 20 age- and sex-matched healthy controls.
- Quantification of MMP-2 and MMP-9 messenger RNA (mRNA) levels using real-time quantitative polymerase chain reaction (PCR).
- Calculation of body mass index (BMI) for all participants.
Main Results:
- No significant differences were observed in MMP-2 and MMP-9 mRNA expression between BD patients and controls.
- MMP mRNA levels did not differ significantly between manic and euthymic states in BD patients.
- MMP-2 mRNA levels showed a negative association with BMI in BD patients, contrasting with a positive association in controls. MMP-9 expression patterns were similar between groups.
Conclusions:
- The association between MMP-2 and BMI differs between bipolar disorder patients and healthy individuals.
- Further research into the role of MMPs in bipolar disorder is warranted to clarify their connection to cardiovascular risk.
- Investigating MMPs may offer insights into managing cardiovascular complications in BD.
Related Concept Videos
Bipolar Disorder
Mania and Antimanic Drugs: Overview
Role of Matrix Metalloproteases in Degradation of ECM
Depression: Overview
Borderline Personality Disorder
Genetic and Environmental Contributions
Borderline Personality...
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
